Literature DB >> 1728400

Molecular dosimetry in rat urine of aflatoxin-N7-guanine and other aflatoxin metabolites by multiple monoclonal antibody affinity chromatography and immunoaffinity/high performance liquid chromatography.

J D Groopman1, J A Hasler, L J Trudel, A Pikul, P R Donahue, G N Wogan.   

Abstract

The development of molecular dosimetry methods will simplify the identification of people at high risk for cancer. A combined monoclonal antibody immunoaffinity chromatography/high performance liquid chromatography method has been devised to isolate and quantify aflatoxin-DNA adducts and other metabolites in rat urine samples. We report the production of 11 different monoclonal antibodies recognizing aflatoxin B1, aflatoxin Q1, aflatoxin G1, aflatoxicol, and aflatoxin M1 and the application of these antibodies to a multiple monoclonal antibody affinity chromatography technique. Using the multiple monoclonal antibody affinity column with rat urines obtained from dosed animals, between 90 and 95% of total aflatoxin metabolites can be bound to the column and isolated. Analytical immunoaffinity chromatography/high performance liquid chromatography analysis of these isolated aflatoxins reveals that more than 55% of the aflatoxins in rat urine are aflatoxin-dihydrodiol, aflatoxin-N7-guanine, aflatoxin Q1, aflatoxin M1, aflatoxin P1, and aflatoxin B1, accounting for 1.5, 9.6, 1.8, 34.5, 8.0, and 1.0% of the total aflatoxins, respectively. Further, a perchloric acid digestion of the aflatoxin-N7-guanine peak was used to confirm its identity by its conversion to guanine. The measurement of aflatoxin-N7-guanine excretion in rat urine was examined to assess its utility as a marker of DNA adduct formation in the liver, and a dose-dependent excretion in urine was found with a correlation coefficient of 0.99. A comparison of the dose-dependent residual levels of aflatoxin binding to liver DNA with the amount of aflatoxin-N7-guanine excreted in urine showed a correlation coefficient of 0.98. Besides the nucleic acid adduct excretion data, aflatoxin M1 and aflatoxin P1 were evaluated as molecular dosimeters in the urine. Aflatoxin M1 was found to be an excellent marker, whereas no linear relationship between dose and aflatoxin P1 excretion in urine was found.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1728400

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  12 in total

1.  Evaluation of the efficacy, acceptability and palatability of calcium montmorillonite clay used to reduce aflatoxin B1 dietary exposure in a crossover study in Kenya.

Authors:  Abigael O Awuor; Ellen Yard; Johnni H Daniel; Collen Martin; Christine Bii; Amelia Romoser; Elvis Oyugi; Sarah Elmore; Samwel Amwayi; John Vulule; Nicholas C Zitomer; Michael E Rybak; Timothy D Phillips; Joel M Montgomery; Lauren S Lewis
Journal:  Food Addit Contam Part A Chem Anal Control Expo Risk Assess       Date:  2017-01

Review 2.  Present and future directions of translational research on aflatoxin and hepatocellular carcinoma. A review.

Authors:  Gerald N Wogan; Thomas W Kensler; John D Groopman
Journal:  Food Addit Contam Part A Chem Anal Control Expo Risk Assess       Date:  2011-06-01

3.  Aflatoxin B1 albumin adducts in plasma and aflatoxin M1 in urine are associated with plasma concentrations of vitamins A and E.

Authors:  Francis A Obuseh; Pauline E Jolly; Yi Jiang; Faisal M B Shuaib; John Waterbor; William O Ellis; Chandrika J Piyathilake; Renee A Desmond; Evans Afriyie-Gyawu; Timothy D Phillips
Journal:  Int J Vitam Nutr Res       Date:  2010-12       Impact factor: 1.784

Review 4.  Aflatoxin: a 50-year odyssey of mechanistic and translational toxicology.

Authors:  Thomas W Kensler; Bill D Roebuck; Gerald N Wogan; John D Groopman
Journal:  Toxicol Sci       Date:  2010-09-29       Impact factor: 4.849

5.  Assessment of safety/risk vs. Public health concerns: Aflatoxins and hepatocarcinoma.

Authors:  Frank C Lu
Journal:  Environ Health Prev Med       Date:  2003-01       Impact factor: 3.674

6.  Calcium montmorillonite clay reduces AFB1 and FB1 biomarkers in rats exposed to single and co-exposures of aflatoxin and fumonisin.

Authors:  Nicole J Mitchell; Kathy S Xue; Shuhan Lin; Alicia Marroquin-Cardona; Kristal A Brown; Sarah E Elmore; Lili Tang; Amelia Romoser; Wentzel C A Gelderblom; Jia-Sheng Wang; Timothy D Phillips
Journal:  J Appl Toxicol       Date:  2013-11-06       Impact factor: 3.446

Review 7.  Human DNA adduct measurements: state of the art.

Authors:  M C Poirier; A Weston
Journal:  Environ Health Perspect       Date:  1996-10       Impact factor: 9.031

Review 8.  Molecular epizootiology: assessment of exposure to genotoxic compounds in teleosts.

Authors:  J E Stein; W L Reichert; U Varanasi
Journal:  Environ Health Perspect       Date:  1994-12       Impact factor: 9.031

9.  Molecular epidemiology of aflatoxin exposures: validation of aflatoxin-N7-guanine levels in urine as a biomarker in experimental rat models and humans.

Authors:  J D Groopman; C P Wild; J Hasler; C Junshi; G N Wogan; T W Kensler
Journal:  Environ Health Perspect       Date:  1993-03       Impact factor: 9.031

10.  A proposed framework for the interpretation of biomonitoring data.

Authors:  Peter J Boogaard; Chris D Money
Journal:  Environ Health       Date:  2008-06-05       Impact factor: 5.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.